Phone: (414) 918-9822    Email: [email protected]

Applications for CARRA-Arthritis Foundation Small and Large Grants due October 1

 

Now Accepting Applications
CARRA-Arthritis Foundation Small and Large Grants
Applications due October 1, 2018

The October 1, 2018 deadline for the CARRA-Arthritis Foundation Small and Large Grant funding opportunities is quickly approaching! Click on the "Submit a Small Grant" or "Submit a Large Grant" buttons below to submit your application.

For the Small Grant, eligible investigators can apply for up to $25,000 in total project costs. The research project can be a pilot, continuation of ongoing research, or other projects that move forward clinical or translational research that furthers the CARRA mission. Preference will be given to research that is collaborative in nature, which leverage current CARRA network resources and/or will further develop the CARRA network. New or early investigators are encouraged to apply and will be afforded special consideration. Please click here for the CARRA-Arthritis Foundation Small Grant Application requirements.

For the Large Grant, letters of intent (LOIs) were due on September 1. Eligible investigators who submitted their LOIs by September 1 can apply for up to $50,000 in total project costs. This funding opportunity supports the development and publication of a clinical or translational project which will immediately impact research projects within CARRA or result in a larger collaborative grant that furthers the CARRA mission. Please click here for the CARRA-Arthritis Foundation Large Grant Application requirements.

If you are planning to submit for the upcoming cycle, please review all information available on the CARRA website prior to starting your application. If you have any questions about eligibility, budget or the submission process, please contact Portlynne Joseph ([email protected]). Remember to use the templates provided when you submit your final application. Applications that do not follow the guidelines will not be considered.